이미지 검색을 사용해 보세요
검색창 이전화면 이전화면
최근 검색어
인기 검색어

소득공제 PDF
eBook Methods & Principles in Medicinal Chemistry
스마트한 PDF 필기 기능을 사용해 보세요!
가격
280,850원
280,850
YES포인트?
14,040원 (5%)
5만원 이상 구매 시 2천원 추가 적립
결제혜택
카드/간편결제 혜택을 확인하세요
PDF 안내

이 상품은 구매 후 지원 기기에서 예스24 eBook앱 설치 후 바로 이용 가능한 상품입니다.

예스24만의 독보적인 PDF 필기 기능을 경험해 보세요!

소개

목차

Series Editors Preface xi
Preface xiii
Acknowledgements xv
List of Abbreviations xvii

1 Introduction to the Science of Pharmacology 1
1.1 Essentials of Reaction Kinetics 5
1.1.1 Reaction Orders 5
1.1.2 Reversible Reactions 10
1.1.3 Multistep (Complex or Consecutive) Reactions 14
1.2 Mass Transfer Fundamentals 17
1.2.1 Erratic Particle Movement in Fluids 19
1.2.2 Particle Movement Along Concentration Gradients (Convective Mass Transfer) 20
1.3 Drug Binding Essentials 24
1.3.1 Substrate Binding to Proteins 24
1.3.2 Enzyme- (and Transporter-) Catalyzed Reactions 29
1.4 General Compound Ionization Relationships 53

2 Pharmacokinetic Fundamentals 61
2.1 Basic Elements of Pharmacokinetics 61
2.1.1 General Principles of Drug Concentration vs. Time Relationships 61
2.1.2 Anatomic Considerations and General Terminologies 62
2.1.3 Drug Removal from the Body 68
2.2 Data Analysis in Pharmacokinetics 81
2.2.1 Compartmental Analysis of Concentration vs. Time Relationships 81
2.2.2 Non-compartmental Data Analysis 139

3 Absorption 145
3.1 Estimating the Extent of Absorption 145
3.1.1 Pre-systemic (Oral) Absorption 145
3.1.2 Bioavailability 153
3.2 Mechanisms of Drug Transport 161
3.2.1 Drug Partitioning 161
3.2.2 Drug Transport Across (Biological) Membranes 163
3.2.3 Additional Factors Influencing Drug Transport 187
3.3 (Oral) Absorption Modeling 201
3.3.1 Simple Absorption Models 201
3.3.2 Complex (Mechanistic or Theoretical) Absorption Models 208
3.4 Absorption Classification Systems 221
3.4.1 Biopharmaceutics Classification System (BCS) 221
3.4.2 Developability Classification System (DCS) 225

4 Distribution 235
4.1 Descriptors of Protein Binding 235
4.1.1 Protein Occupancy 235Contents vii
4.1.2 Fractional Protein Binding 243
4.1.3 Protein Binding in Blood 257
4.1.4 Protein Binding in Tissues 266
4.1.5 Protein Turnover 273
4.2 Volume of Distribution 275
4.2.1 Initial (or Central) Volume of Distribution, Vdc 276
4.2.2 Volume of Distribution at Steady State, Vdss 278
4.2.3 Volume of Distribution at Pseudo Steady State or Pseudo-Equilibrium, Vd area 286
4.2.4 Extrapolated Volume of Distribution, Vdextra 288
4.3 Drug Delivery to the Brain 288
4.4 Enterohepatic Circulation 303

5 Elimination 313
5.1 Clearance 314
5.1.1 Systemic (Total Body) Clearance 315
5.1.2 Organ Clearance Concepts 318
5.2 Metabolism 352
5.3 Excretion 366
5.3.1 Renal Excretion 369
5.3.2 Biliary Excretion 376

6 PK Forecasting Concepts 383
6.1 Drug Disposition Classification Systems 383
6.1.1 Lipinski's Rule of Five 383
6.1.2 The Biopharmaceutics Drug Disposition Classification System (BDDCS) 384
6.1.3 Extended Clearance Classification System (ECCS or EC2S) 385
6.1.4 Extended Clearance Concept Classification System (ECCCS or EC3S) 386
6.2 Prediction of Human Pharmacokinetics 389
6.2.1 Prediction of Individual PK Parameters 390
6.2.2 Prediction of Plasma-Concentration Profiles 400

7 Pharmacodynamics 413
7.1 Receptor Binding Fundamentals 415
7.1.1 Ordinary Drug–Receptor Models 415
7.1.2 Atypical (Extraordinary or Unusual) Concentration-Effect Relationships 430
7.2 In Vivo Pharmacology 432
7.2.1 Dose Titration (or Static Dose–Response) Model 435
7.2.2 Open Response Models 437
7.2.3 Safety Indices 447
7.2.4 Concepts for Establishing (Clinically) Relevant Dosage Regimen 455

8 Drug–Drug Interactions 463
8.1 Pharmacokinetic Interactions 463
8.1.1 Pharmacokinetic Interaction Mechanisms 465
8.1.2 Quantifying Drug–Drug Interactions 493
8.2 Pharmacodynamic Drug–Drug Interactions 522
8.2.1 Pharmacodynamics in the Presence of Negative Modulators 523
8.2.2 Pharmacodynamics in the Presence of Positive Modulators 531
8.2.3 Measures of Pharmacodynamic Drug–Drug Interactions 532Contents ix

Appendicies 545

A Engineering Technologies 547
A.1 New Chemical Modalities 547
A.2 Genetically Modified Organisms 548
A.3 Microphysiological Systems 548
A.4 Isotopic Labeling 549

B Research and Development Process 553

C Chemistry 561
C.1 Acids and Bases 561
C.2 Oxidants and Reductants 561
C.3 Isomerism 561
C.4 Analytical Chemistry 564

D Mathematical Sciences 577
D.1 Probability Distribution 577
D.2 Statistical Modeling 582
D.3 Algebra 587
D.4 Calculus 588

E Expression of Enzyme and Transporter Proteins 591
E.1 Liver 591
E.2 Intestine 592
E.3 Kidney 593
E.4 Brain and Blood–Brain Barrier 594
E.5 Lung 595
E.6 Blood/Plasma 595

References 596
Index 597

저자 소개

Gian Peter Camenisch, PhD, is a senior scientist with close to 30 years of pharmaceutical experience across multiple DMPK-related disciplines spanning discovery and early/late development. He brings extensive expertise in managing internal and external interfaces in global environments, with proven success in matrix team management.

관련 분류

품목정보

발행일
2026년 11월 05일
이용안내
  •  배송 없이 구매 후 바로 읽기
  •  이용기간 제한없음
  •   TTS 가능 ?
  •  저작권 보호를 위해 인쇄 기능 제공 안함
지원기기
크레마, PC(윈도우 - 4K 모니터 미지원), 아이폰, 아이패드, 안드로이드폰, 안드로이드패드, PC(Mac)
파일/용량
PDF(DRM) | 14.06MB ?
글자 수/ 페이지 수
약 635쪽 ?
ISBN13
9783527857814
ECN

첫번째 리뷰어가 되어주세요.

첫번째 한줄평을 남겨주세요.

사락 별점0

혜택 및 유의사항

첫번째 별점을 남겨주세요.

첫번째 밑줄을 남겨주세요.